课题基金 / 基金详情

NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORYCONTRACT TYPE: COST, OPTIONPERIOD OF PERFORMANCE: 09/01/2019 TO 08/31/2020

NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORYCONTRACT TYPE: COST, OPTIONPERIOD OF PERFORMANCE: 09/01/2019 TO 08/31/2020
NIH NEUROBOBAN 脑和组织存储库合同类型：成本、期权履行期限：2019 年 9 月 1 日至 2020 年 8 月 31 日
批准号：
10246235
负责人：
BONITA KRALL
金额：
$103.75万
依托单位：
SEPULVEDA RESEARCH CORPORATION
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
项目状态：
已结题
起止时间：
2019-09-01 至 2020-08-31
来源：
https://reporter.nih.gov/project-details/10246235
关键词：
AdvocacyAutopsyBrainCollectionCommunitiesContractsDiseaseGoalsHumanMental disordersNational Institute of Child Health and Human DevelopmentNational Institute of Drug AbuseNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Institute on AgingNeurodevelopmental DisorderPatientsPerformanceProcessResearchResourcesSiteTissue BanksTissuesUnited States National Institutes of Healthbrain tissuecosthuman diseasemind controlnervous system disorder

项目摘要

项目成果

BONITA KRALL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"This contract is for post-mortem human brain collection sites (i.e. the NIH Brain and Tissue Repositories [NBTR]) for the NIH NeuroBioBank. This contract is part of a strategy by the NIH to maximize availability of post-mortem human biospecimens to the research community while simultaneously achieving greater efficiency and better coordination of brain and tissue repository resources through a centralized approach to brain banking."
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORYCONTRACT TYPE: COST, OPTIONPERIOD OF PERFORMANCE: 09/01/2019 TO 08/31/2020
NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORYCONTRACT TYPE: COST, OPTIONPERIOD OF PERFORMANCE: 09/01/2019 TO 08/31/2020
NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORYCONTRACT TYPE: COST, OPTIONPERIOD OF PERFORMANCE: 09/01/2019 TO 08/31/2020
  • 批准号：
    10030249
  • 项目类别：
  • 资助金额：
    $96.24万
  • 财政年份：
    2019
  • 负责人：
    BONITA KRALL
  • 依托单位：
    SEPULVEDA RESEARCH CORPORATION
海外基金